ALGS vs CF · rev $3.6M vs P/E 12, rev $5.94B
Aligos Therapeutics Inc (ALGS) versus CF Industries Holdings Inc (CF) — a side-by-side from cached financials, not a winner call.
Aligos Therapeutics Inc (ALGS) is a biotechnology company listed on US.
CF Industries Holdings Inc (CF) is a agricultural inputs company listed on US.
Latest reported ALGS revenue for 2024-12-31 was $3.6M. Net income was -$131.2M. Revenue was down 41.7% from 2023-12-31 to 2024-12-31. ALGS currently screens at market cap $44.1M.
Latest reported CF revenue for 2024-12-31 was $5.94B. Net income was $1.48B. Revenue was down 10.5% from 2023-12-31 to 2024-12-31. CF currently screens at market cap $14.98B and trailing P/E 12.2.
ALGS currently screens at market cap $44.1M. CF currently screens at market cap $14.98B and trailing P/E 12.2.
Not investment advice. Open the ALGS and CF stock pages for the full models.
Not investment advice.